切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - 5-HT7 Receptors - ULK1 - MAPKAP-K2 - NMDA Receptors

10 件产品

每页
清除全部
  1. SBI-0206965
    A8715 SBI-0206965
     2 Citation
    Target: ULK1
    Summary: ULK1抑制剂
      ≥24.47 mg/mL
      insoluble in H2O
  2. Rottlerin
    B6803 Rottlerin
     1 Citation
    中文名: 揪毒素
    Target: PKC|Ca2 /calmodulin-dependent protein kinases (CaMKs)|PRAK|MAPKAP-K2
    Summary: PKC抑制剂
      ≥23.6 mg/mL
      insoluble in H2O
  3. (RS)-CPP
    B6214 (RS)-CPP
    Target: NMDA Receptors
    Summary: NMDA拮抗剂
      <25.22 mg/mL
  4. Spermidine trihydrochloride
    B6523 Spermidine trihydrochloride
    中文名: 三盐酸亚精胺
    Target: NMDA Receptors
    Summary: NMDA受体激动剂
      insoluble in DMSO
      ≥10 mg/mL
  5. Lurasidone HCl
    B1477 Lurasidone HCl
    中文名: 盐酸鲁拉西酮
    Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂
      ≥11.11 mg/mL
      insoluble in H2O
  6. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    中文名: 富马酸奎硫平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥11.03 mg/mL
      insoluble in H2O
  7. (-)-MK 801
    B1627 (-)-MK 801
    Target: NMDA Receptors
    Summary: 有效的NMDA选择性拮抗剂
      ≥10.3 mg/mL
      insoluble in H2O
  8. Vortioxetine
    A3926 Vortioxetine
    中文名: 沃替西汀
    Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERT
    Summary: 5-HT受体拮抗剂
      ≥14.92 mg/mL
      insoluble in H2O
  9. (+)-MK 801
    A3100 (+)-MK 801
    Target: NMDA Receptors
    Summary: NMDA拮抗剂
      ≥10.45 mg/mL
      insoluble in H2O
  10. (-)-Huperzine A
    A1932 (-)-Huperzine A
    中文名: 石杉碱甲
    Target: NMDA Receptors|AChE
    Summary: NMDA受体拮抗剂/AChE抑制剂
      ≥12.12 mg/mL
      insoluble in H2O

10 件产品

每页